학술논문
Alternative Complement Pathway Inhibition With Iptacopan for the Treatment of C3 Glomerulopathy-Study Design of the APPEAR-C3G Trial
Document Type
Article
Author
Source
In Kidney International Reports October 2022 7(10):2150-2159
Subject
Language
ISSN
2468-0249